NO145539C - Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av ditiepino-(1,4)(2,3-c)-pyrrol - Google Patents

Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av ditiepino-(1,4)(2,3-c)-pyrrol

Info

Publication number
NO145539C
NO145539C NO770552A NO770552A NO145539C NO 145539 C NO145539 C NO 145539C NO 770552 A NO770552 A NO 770552A NO 770552 A NO770552 A NO 770552A NO 145539 C NO145539 C NO 145539C
Authority
NO
Norway
Prior art keywords
ditiepino
pyrrol
preparation
new therapeutic
active derivatives
Prior art date
Application number
NO770552A
Other languages
English (en)
Other versions
NO770552L (no
NO145539B (no
Inventor
Claude Jeanmart
Andre Leger
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7604713A external-priority patent/FR2341312A1/fr
Priority claimed from FR7635096A external-priority patent/FR2371198A2/fr
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of NO770552L publication Critical patent/NO770552L/no
Publication of NO145539B publication Critical patent/NO145539B/no
Publication of NO145539C publication Critical patent/NO145539C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205Radicals derived from carbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO770552A 1976-02-20 1977-02-18 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av ditiepino-(1,4)(2,3-c)-pyrrol NO145539C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7604713A FR2341312A1 (fr) 1976-02-20 1976-02-20 Nouveaux derives du dithiepinno (1,4) (2,3-c) pyrrolle, leur preparation et les compositions qui les contiennent
FR7635096A FR2371198A2 (fr) 1976-11-22 1976-11-22 Nouveaux derives du dithiepinno (1,4)(2,3-c) pyrrole, leur preparation et les compositions qui les contiennent

Publications (3)

Publication Number Publication Date
NO770552L NO770552L (no) 1977-08-23
NO145539B NO145539B (no) 1982-01-04
NO145539C true NO145539C (no) 1982-04-14

Family

ID=26219306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO770552A NO145539C (no) 1976-02-20 1977-02-18 Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av ditiepino-(1,4)(2,3-c)-pyrrol

Country Status (23)

Country Link
US (1) US4124711A (no)
JP (1) JPS52100495A (no)
AR (1) AR218261A1 (no)
AT (1) AT350577B (no)
AU (1) AU503745B2 (no)
CA (1) CA1072557A (no)
CH (1) CH620443A5 (no)
DE (1) DE2707072C2 (no)
DK (1) DK146069C (no)
ES (2) ES456041A1 (no)
FI (1) FI61190C (no)
GB (1) GB1512620A (no)
HU (1) HU172292B (no)
IE (1) IE44564B1 (no)
LU (1) LU76799A1 (no)
NL (1) NL7701487A (no)
NO (1) NO145539C (no)
NZ (1) NZ183366A (no)
PH (1) PH12628A (no)
PT (1) PT66203B (no)
SE (1) SE427353B (no)
SU (2) SU869559A3 (no)
YU (2) YU39990B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2451380A1 (fr) * 1979-03-15 1980-10-10 Rhone Poulenc Ind Nouveaux derives du dithiepinno (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent
EP0091241B1 (en) * 1982-04-02 1988-12-28 Takeda Chemical Industries, Ltd. Condensed pyrrolinone derivatives, and their production
FR2525605A1 (fr) * 1982-04-22 1983-10-28 Rhone Poulenc Sante Nouveaux derives du dithiinno (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207555A1 (es) * 1972-12-04 1976-10-15 Procedimiento para preparar aril-6-piperazinocarboniloxi-5 oxo-7 tetrahidro-2,3,6,7 ditiino(1,4)(2,3-c)pirroles
ZA756953B (en) * 1974-11-07 1976-10-27 Rhone Poulenc Ind 1,4-oxathiino(2,3-c)pyrrole derivatives

Also Published As

Publication number Publication date
CH620443A5 (no) 1980-11-28
PT66203B (fr) 1978-08-12
JPS52100495A (en) 1977-08-23
SE7701843L (sv) 1977-08-21
AU503745B2 (en) 1979-09-20
YU39990B (en) 1985-06-30
SU869559A3 (ru) 1981-09-30
SU674672A3 (ru) 1979-07-15
FI770530A (no) 1977-08-21
SE427353B (sv) 1983-03-28
IE44564B1 (en) 1982-01-13
GB1512620A (en) 1978-06-01
ATA109977A (de) 1978-11-15
IE44564L (en) 1977-08-20
NO770552L (no) 1977-08-23
LU76799A1 (no) 1977-09-12
DK71877A (da) 1977-08-21
DK146069B (da) 1983-06-20
ES456041A1 (es) 1978-05-01
DK146069C (da) 1983-11-14
AR218261A1 (es) 1980-05-30
HU172292B (hu) 1978-07-28
YU45877A (en) 1982-10-31
PT66203A (fr) 1977-03-01
NL7701487A (nl) 1977-08-23
DE2707072C2 (de) 1985-09-12
NZ183366A (en) 1978-09-20
CA1072557A (fr) 1980-02-26
AU2240177A (en) 1978-08-24
US4124711A (en) 1978-11-07
FI61190B (fi) 1982-02-26
PH12628A (en) 1979-07-05
YU40082B (en) 1985-06-30
NO145539B (no) 1982-01-04
FI61190C (fi) 1982-06-10
ES457260A1 (es) 1978-06-01
JPS6145625B2 (no) 1986-10-08
DE2707072A1 (de) 1977-08-25
AT350577B (de) 1979-06-11
YU162782A (en) 1982-10-31

Similar Documents

Publication Publication Date Title
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
NO156752B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
MX3565E (es) Procedimiento de preparacion de derivados de la tieno(2,3-c)-piridina
NO147148C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO148642C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater
NO148926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO152654C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO150882C (no) Analogifremgangsmaate ved fremstilling av nye 1,4-benzoksazin-derivater
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO145539C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av ditiepino-(1,4)(2,3-c)-pyrrol
NO147749C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive n-acryl-2-hydroxy-1,3-diaminopropaner
NO151324C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-fenyl-tieno(2,3-c)-piperidin-forbindelser
NO149209C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-(3-(3,4,5-trimetoksyfenoksy)-2-hydroksypropyl))-4-aryl-piperazin-derivater
NO146600C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater
NO143534C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av oxatiino(1,4)(2,3-c)pyrrol.
NO145882C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2,3,8,12b-tetrahydro-1h-3a,8-methandibenzo(3,4:6,7)-cyclo-hepta(1,2-c)pyrrol-derivater
NO772739L (no) Fremgangsm}te til fremstilling av nye, substituerte 2,3-alkylen-bis(oksy)benzamider og deres derivater